IDXX
NASDAQ
US
IDEXX Laboratories, Inc. - Common Stock
$569,55
▲ +$4,89
(+0,87%)
Vol 734K
11
Score de Qualité
ok
Analyse approfondie
2/5
ok
CA ✓
RN ✓
>IPO ✗
Cap. boursière
$54.0B
P/E
52,6
ROE
67,8%
Marge
24,7%
D/E
62,76
Beta
1,67
52W
$356–$770
Consensus Wall Street
22 analystes · Avr 20267
Achat fort
9
Achat
6
Conserver
0
Vente
0
Vente forte
72,7%
Note d'achat
Graphique de Prix
Actions similaires
Bénéfices
Taux de dépassement: 100,0%| Trimestre | BPA est. | BPA réel | Surprise |
|---|---|---|---|
| Déc 2025 | $2,99 | $3,08 | +$0,09 |
| Sep 2025 | $3,19 | $3,40 | +$0,21 |
| Jui 2025 | $3,37 | $3,63 | +$0,26 |
| Mar 2025 | $2,91 | $2,96 | +$0,05 |
Chiffre d'affaires et résultats trimestriels
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenu | $954.3M | $998.4M | $1.1B | $1.1B | $1.1B |
| Résultat net | $216.1M | $242.7M | $294.0M | $274.6M | $248.2M |
Tendance des fondamentaux
| Métrique | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 64.4% | 64.4% | 64.4% | 64.4% | 67.8% | 67.8% |
| P/E (TTM) | 43.76 | 51.66 | 48.97 | 51.10 | 57.24 | 52.58 |
| Net Margin | 26.5% | 24.4% | 24.4% | 24.4% | 24.6% | 24.6% |
| Gross Margin | 62.6% | 61.5% | 61.5% | 61.5% | 61.7% | 61.7% |
| D/E Ratio | 75.66 | 75.66 | 75.66 | 75.66 | 62.76 | 62.76 |
| Current Ratio | 1.11 | 1.11 | 1.11 | 1.11 | 1.18 | 1.18 |
Ratios clés
ROA (TTM)
31,1%
P/S (TTM)
12,96
P/B
21,2
EPS (TTM)
$12,61
CF/Share
$11,16
Croiss. CA 3A
+6,6%
52W High
$769,98
52W Low
$356,14
$356,14
Plage 52 semaines
$769,98
Santé financière
Flux de trésorerie libre
$326.1M
Dette nette
$796.0M
Trésorerie
$180.1M
Dette totale
$976.1M
Au Déc 31, 2025
Як IDXX виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка IDXX vs аналоги Health Care
Ratio P/E
52,6
▲
71%
au-dessus
pairs
(30,7)
vs Pairs
vs Industrie
Sous-évalué
Ratio P/S
13,0
▲
402%
au-dessus
pairs
(2,6)
vs Pairs
vs Industrie
Surévalué
Ratio P/B
21,2
▲
663%
au-dessus
pairs
(2,8)
vs Pairs
vs Industrie
Surévalué
Rendement dividende
—
▼
0%
en dessous
pairs
(0,7%)
vs Pairs
vs Industrie
Faible rendement
Прибутковість IDXX vs аналоги Health Care
ROE
67,8%
▲
276%
au-dessus
pairs
(-38,5%)
vs Pairs
vs Industrie
Premier rang
Net margin
24,7%
▲
200%
au-dessus
pairs
(-24,7%)
vs Pairs
vs Industrie
Premier rang
Marge brute
61,7%
▲
17%
au-dessus
pairs
(52,9%)
vs Pairs
vs Industrie
Sous la moyenne
ROA
31,1%
▲
246%
au-dessus
pairs
(-21,2%)
vs Pairs
vs Industrie
Premier rang
Фінансове здоровʼя IDXX vs аналоги Health Care
Ratio D/E
62,8
▲
226%
au-dessus
pairs
(19,3)
vs Pairs
vs Industrie
Fort endettement
Ratio de liquidité
1,2
▼
45%
en dessous
pairs
(2,2)
vs Pairs
vs Industrie
Faible liquidité
Beta
1,7
▲
59%
au-dessus
pairs
(1,1)
vs Pairs
vs Industrie
Plus volatil
Радар фундаменталів IDXX
IDXX
Médiane des pairs
Industrie
IDXX прибутковість vs борг
Taille = capitalisation · X = marge nette · Y = Ratio D/E
IDXX vs аналоги: ключові метрики
Dernier avis AI
Grok
SKIP
Price action shows a prolonged downtrend from peaks above $750 in late 2025 to current levels around $558, with recent weekly closes declining from $636 (Mar 2) to $557 (Mar 30), indicating no clear reversal or upward momentum yet, making …
Avr 01, 2026